Clinical Trials Directory

Trials / Unknown

UnknownNCT01197092

The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II

A Study Evaluating the Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Center for Integrative Medicine, Germany · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

A treatment with the concept of mitochondrial medication developed by Dr Heinrich Kremer can demonstrably improve and successfully treat actual parameters of Diabetes Mellitus II as well as its risk factors.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMitochondrial preparationsOral therapy with mitochondrial preparations based on recipes of Dr Kremer and the Tisso company: ProEMSan (large intestinal symbionts with 31 strains of bacteria) Pro Basan (small intestinal symbionts) ProSirtusan (Polyphenol-mix and vitamins) ProVita D3 (Vitamin D3 supplement) ProOmega (Omega 3-fatty acid preparation) ProCarnitin (Carnitine-preparation) ProSango Vital (trace element preparation)
DIETARY_SUPPLEMENTInfusion therapyInfusion therapy in the form of a complex mix: 500ml-solution with trace elements, amino acids and antioxidants.
DEVICEWebermedical deviceIntravenous-Blood-Laser-Therapy: the Webermedical device will be used
BEHAVIORALNutritional therapyNutritional therapy based on IgG-blood results. Significant antibody-formation against foodstuffs will be ascertained (in foodstuffs evaluated through the BioMedicalScreen), will be taken out of the diet - the background being the additional lowering of risk potential of those antibodies causing the so called "silent inflammation" (sub-clinical inflammation) -ultimately an anti-inflammatory diet will be given in the protocol. The following have special focus: gluten, cow's milk, fish, meat, nuts.

Timeline

Start date
2010-11-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2010-09-09
Last updated
2010-11-16

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01197092. Inclusion in this directory is not an endorsement.